EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL.pdf (1.76 MB)
EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL – Supplemental material for Endpoints for randomized controlled clinical trials for COVID-19 treatments
journal contribution
posted on 2020-07-18, 12:08 authored by Lori E Dodd, Dean Follmann, Jing Wang, Franz Koenig, Lisa L Korn, Christian Schoergenhofer, Michael Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski, Drifa Belhadi, Yeming Wang, Bin Cao, France Mentre, Thomas JakiSupplemental material, EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL for Endpoints for randomized controlled clinical trials for COVID-19 treatments by Lori E Dodd, Dean Follmann, Jing Wang, Franz Koenig, Lisa L Korn, Christian Schoergenhofer, Michael Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski, Drifa Belhadi, Yeming Wang, Bin Cao, France Mentre and Thomas Jaki in Clinical Trials